Key Takeaways
1. Samsung is enhancing ECG capabilities in Galaxy smartwatches to detect early symptoms of Left Ventricular Systolic Dysfunction (LVSD).
2. LVSD is linked to about 50% of heart failure cases, and early detection could potentially lower death risk, though no supporting data is provided.
3. The LVSD detection feature was developed in collaboration with Medical AI and is based on data from over 120,000 patients.
4. The feature has been approved by the Ministry of Food and Drug Safety (MFDS) in South Korea, making it a first for smartwatches.
5. The LVSD detection tool will be available on the Galaxy Watch8 and Watch Ultra in Korea, with uncertain availability in other regions.
Samsung is working on a new health feature for some of its Galaxy smartwatches. This upcoming tool enhances the current electrocardiogram (ECG) capabilities, which already help monitor users’ heart rate and blood pressure.
New Detection Capabilities
A recent press release from Samsung reveals that its Galaxy smartwatches will be capable of identifying early symptoms of Left Ventricular Systolic Dysfunction (LVSD). This condition is responsible for about 50% of all heart failure cases, as per the company’s information. Samsung claims that catching this disease early could lower the risk of death, yet they don’t provide any data to support this assertion.
Collaboration with Medical AI
The LVSD detection feature was created alongside the Korean medical device firm Medical AI. The algorithm is based on data from over 120,000 patients in Korean hospitals and has been approved by the Ministry of Food and Drug Safety (MFDS) in South Korea. This makes the Samsung Galaxy Watch the first smartwatch to offer a certified LVSD detection feature.
Availability and Pricing
Samsung’s LVSD detection tool will be available on two models in Korea: the Watch8 and the Watch Ultra (curr. $649.99 at Amazon). It remains uncertain if or when this feature will receive approval for other regions like North America or Europe.
Source:
Link
Leave a Reply